In response to your query on UCM (Mcap $64m). They don't have a preventative (ie Anti Corona virus) product they sell devices that monitor cardiovascular/ pulmonary conditions. And there has been increased demand for their products from China due to Virus.
HCT (Mcap: $45) still remains the cheapest value/mcap wise of the preventative Corona Virus product group.
When HCT announce +ive results of their Covid-19 testing it will catch up to the pack and possibly overtake them.
All is IMHO
In response to your query on UCM (Mcap $64m). They don't have a...
Add HCT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1088204 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 453395 | 3 |
View Market Depth
| Last trade - 10.04am 10/07/2024 (20 minute delay) ? |
| HCT (ASX) Chart |
Day chart unavailable